Exact Imaging
PrivateLast Round
VC Round
Feb 10, 2026
Total Funding Raised
$43.29M
Company Overview
Exact Imaging is a medical device company that develops high-resolution micro-ultrasound systems for urologic imaging and real-time prostate biopsy guidance.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exact Imaging Comps
Public and private peers based on sector, stage, and business model.
Exact Imaging Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 10, 2026 | ||||
| Debt | Mar 23, 2021 | ||||
| Series C | Jan 5, 2017 | ||||
| Series C | Dec 1, 2016 | ||||
| Grant | Apr 30, 2015 | ||||
Series B | May 30, 2014 |
Exact Imaging Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BDC Capital | Debt |
| Vesalius Biocapital Partners | Series C |
| Veddis | Series B |
| FedDev Ontario | Grant |
| PMV | Series C |
| Export Development Canada | Debt |
| Lumira Ventures | Series C |
Exact Imaging Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exact Imaging's valuation, stock price, and market status.